JP2004535473A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004535473A5 JP2004535473A5 JP2003515226A JP2003515226A JP2004535473A5 JP 2004535473 A5 JP2004535473 A5 JP 2004535473A5 JP 2003515226 A JP2003515226 A JP 2003515226A JP 2003515226 A JP2003515226 A JP 2003515226A JP 2004535473 A5 JP2004535473 A5 JP 2004535473A5
- Authority
- JP
- Japan
- Prior art keywords
- implant
- sustained release
- tablet
- pharmaceutically active
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000013268 sustained release Methods 0.000 claims 44
- 239000012730 sustained-release form Substances 0.000 claims 44
- 239000007943 implant Substances 0.000 claims 43
- 239000008185 minitablet Substances 0.000 claims 26
- 239000003826 tablet Substances 0.000 claims 20
- 239000004480 active ingredient Substances 0.000 claims 17
- 239000000203 mixture Substances 0.000 claims 12
- 238000011282 treatment Methods 0.000 claims 10
- 230000000507 anthelmentic effect Effects 0.000 claims 9
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 9
- 230000036765 blood level Effects 0.000 claims 7
- 229940079593 drug Drugs 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 5
- 108010051696 Growth Hormone Proteins 0.000 claims 4
- 102000018997 Growth Hormone Human genes 0.000 claims 4
- 241001465754 Metazoa Species 0.000 claims 4
- 239000000122 growth hormone Substances 0.000 claims 4
- 150000002596 lactones Chemical class 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 230000001737 promoting effect Effects 0.000 claims 4
- 241000283690 Bos taurus Species 0.000 claims 3
- 241000282414 Homo sapiens Species 0.000 claims 3
- -1 antidiabetics Substances 0.000 claims 3
- 239000003102 growth factor Substances 0.000 claims 3
- 239000005556 hormone Substances 0.000 claims 3
- 229940088597 hormone Drugs 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims 2
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- 241000238631 Hexapoda Species 0.000 claims 2
- 241000282412 Homo Species 0.000 claims 2
- 241001494479 Pecora Species 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 229940035676 analgesics Drugs 0.000 claims 2
- 239000000730 antalgic agent Substances 0.000 claims 2
- 239000000921 anthelmintic agent Substances 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- 239000003096 antiparasitic agent Substances 0.000 claims 2
- 229940125687 antiparasitic agent Drugs 0.000 claims 2
- 230000004323 axial length Effects 0.000 claims 2
- 108010015046 cell aggregation factors Proteins 0.000 claims 2
- 239000007891 compressed tablet Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 239000003630 growth substance Substances 0.000 claims 2
- 230000003394 haemopoietic effect Effects 0.000 claims 2
- 229960002418 ivermectin Drugs 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 239000008188 pellet Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229920001296 polysiloxane Polymers 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 239000000377 silicon dioxide Substances 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 241000251468 Actinopterygii Species 0.000 claims 1
- 241000272517 Anseriformes Species 0.000 claims 1
- 241000271566 Aves Species 0.000 claims 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 claims 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 claims 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 1
- 241000282832 Camelidae Species 0.000 claims 1
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- 241000283707 Capra Species 0.000 claims 1
- 241000938605 Crocodylia Species 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 241000283086 Equidae Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims 1
- 241000287828 Gallus gallus Species 0.000 claims 1
- 241000289419 Metatheria Species 0.000 claims 1
- 241000699670 Mus sp. Species 0.000 claims 1
- 241000282339 Mustela Species 0.000 claims 1
- 108010025020 Nerve Growth Factor Proteins 0.000 claims 1
- 102000007072 Nerve Growth Factors Human genes 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 241000283973 Oryctolagus cuniculus Species 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 101000868138 Ovis aries Somatotropin Proteins 0.000 claims 1
- 241000286209 Phasianidae Species 0.000 claims 1
- 241000288906 Primates Species 0.000 claims 1
- 241000700159 Rattus Species 0.000 claims 1
- 241000283984 Rodentia Species 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 229910001514 alkali metal chloride Inorganic materials 0.000 claims 1
- 229940124325 anabolic agent Drugs 0.000 claims 1
- 239000003263 anabolic agent Substances 0.000 claims 1
- 230000003444 anaesthetic effect Effects 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 claims 1
- 229940069428 antacid Drugs 0.000 claims 1
- 239000003159 antacid agent Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000001458 anti-acid effect Effects 0.000 claims 1
- 230000001165 anti-coccidial effect Effects 0.000 claims 1
- 230000001773 anti-convulsant effect Effects 0.000 claims 1
- 230000003178 anti-diabetic effect Effects 0.000 claims 1
- 230000001387 anti-histamine Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 229940124346 antiarthritic agent Drugs 0.000 claims 1
- 239000001961 anticonvulsive agent Substances 0.000 claims 1
- 229960003965 antiepileptics Drugs 0.000 claims 1
- 229940030225 antihemorrhagics Drugs 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 229960005475 antiinfective agent Drugs 0.000 claims 1
- 239000003904 antiprotozoal agent Substances 0.000 claims 1
- 239000003435 antirheumatic agent Substances 0.000 claims 1
- 239000003699 antiulcer agent Substances 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 230000003542 behavioural effect Effects 0.000 claims 1
- 229960000074 biopharmaceutical Drugs 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000003114 blood coagulation factor Substances 0.000 claims 1
- 229940019700 blood coagulation factors Drugs 0.000 claims 1
- 239000003633 blood substitute Substances 0.000 claims 1
- 230000036760 body temperature Effects 0.000 claims 1
- 230000004097 bone metabolism Effects 0.000 claims 1
- 108010006025 bovine growth hormone Proteins 0.000 claims 1
- 229940124630 bronchodilator Drugs 0.000 claims 1
- 239000000168 bronchodilator agent Substances 0.000 claims 1
- 239000003560 cancer drug Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical group 0.000 claims 1
- 239000003576 central nervous system agent Substances 0.000 claims 1
- 235000013330 chicken meat Nutrition 0.000 claims 1
- 229940124558 contraceptive agent Drugs 0.000 claims 1
- 239000003433 contraceptive agent Substances 0.000 claims 1
- 239000002872 contrast media Substances 0.000 claims 1
- 229960003964 deoxycholic acid Drugs 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 239000002934 diuretic Substances 0.000 claims 1
- 229940030606 diuretics Drugs 0.000 claims 1
- 239000003172 expectorant agent Substances 0.000 claims 1
- 230000003419 expectorant effect Effects 0.000 claims 1
- 229940066493 expectorants Drugs 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 229940012356 eye drops Drugs 0.000 claims 1
- 229910021485 fumed silica Inorganic materials 0.000 claims 1
- 239000007952 growth promoter Substances 0.000 claims 1
- 239000002874 hemostatic agent Substances 0.000 claims 1
- 230000002439 hemostatic effect Effects 0.000 claims 1
- 210000003494 hepatocyte Anatomy 0.000 claims 1
- 238000002657 hormone replacement therapy Methods 0.000 claims 1
- 229960001438 immunostimulant agent Drugs 0.000 claims 1
- 239000003022 immunostimulating agent Substances 0.000 claims 1
- 230000003308 immunostimulating effect Effects 0.000 claims 1
- 239000003018 immunosuppressive agent Substances 0.000 claims 1
- 229940125721 immunosuppressive agent Drugs 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 229910017053 inorganic salt Inorganic materials 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 230000003340 mental effect Effects 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 229940035363 muscle relaxants Drugs 0.000 claims 1
- 239000003158 myorelaxant agent Substances 0.000 claims 1
- 229930014626 natural product Natural products 0.000 claims 1
- 239000003900 neurotrophic factor Substances 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 230000016087 ovulation Effects 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
- 239000002210 silicon-based material Substances 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR6024 | 2001-06-29 | ||
| AUPR6024A AUPR602401A0 (en) | 2001-06-29 | 2001-06-29 | Sustained release delivery system |
| PCT/AU2002/000866 WO2003009833A1 (en) | 2001-06-29 | 2002-07-01 | Sustained release delivery system |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004535473A JP2004535473A (ja) | 2004-11-25 |
| JP2004535473A5 true JP2004535473A5 (https=) | 2005-10-27 |
| JP4913321B2 JP4913321B2 (ja) | 2012-04-11 |
Family
ID=3829990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003515226A Expired - Fee Related JP4913321B2 (ja) | 2001-06-29 | 2002-07-01 | 徐放性医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8197839B2 (https=) |
| EP (1) | EP1411905A4 (https=) |
| JP (1) | JP4913321B2 (https=) |
| CN (1) | CN1536988A (https=) |
| AU (2) | AUPR602401A0 (https=) |
| BR (1) | BR0210630A (https=) |
| CA (1) | CA2452075C (https=) |
| NZ (1) | NZ529858A (https=) |
| WO (1) | WO2003009833A1 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6375972B1 (en) | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| WO2003022242A1 (en) * | 2001-09-11 | 2003-03-20 | Smart Drug Systems Inc | Preparation of sustained release pharmaceutical composition |
| NZ581461A (en) * | 2003-11-13 | 2011-04-29 | Psivida Inc | Injectable sustained release delivery devices |
| CN101683317A (zh) * | 2004-05-31 | 2010-03-31 | 斯玛特药物系统公司 | 缓释组合物 |
| PT1781264E (pt) | 2004-08-04 | 2013-10-16 | Evonik Corp | Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma |
| WO2007123511A2 (en) * | 2006-03-24 | 2007-11-01 | Infinity Pharmaceuticals, Inc. | Dosing regimens for the treatment of cancer |
| US20090005869A1 (en) * | 2006-12-15 | 2009-01-01 | University Of Virginia Patent Foundation | Device which Attaches into a Joint and Carries a Payload of Controlled Release Drugs and Related Method thereof |
| NZ552290A (en) * | 2006-12-21 | 2009-05-31 | Bomac Research Ltd | Tablet fomulation |
| TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類 |
| ES2718612T3 (es) | 2007-12-20 | 2019-07-03 | Evonik Corp | Procedimiento para preparar micropartículas que tienen un bajo volumen de disolvente residual |
| US20100297118A1 (en) * | 2007-12-27 | 2010-11-25 | Macdougall John | Therapeutic Cancer Treatments |
| WO2009086416A1 (en) * | 2007-12-27 | 2009-07-09 | Infinity Pharmaceuticals, Inc. | Therapeutic cancer treatments |
| AU2008345097A1 (en) | 2007-12-27 | 2009-07-09 | Infinity Pharmaceuticals, Inc. | Methods for stereoselective reduction |
| US9005649B2 (en) | 2009-07-14 | 2015-04-14 | Board Of Regents, The University Of Texas System | Methods for making controlled delivery devices having zero order kinetics |
| JP6141015B2 (ja) | 2009-08-05 | 2017-06-07 | インフィニティ ファーマスーティカルズ、インク． | シクロパミン類似体の酵素によるアミノ基転移 |
| US20110183948A1 (en) * | 2010-01-15 | 2011-07-28 | Infinity Pharmaceuticals, Inc. | Treatment of fibrotic conditions using hedgehog inhibitors |
| US9394313B2 (en) | 2010-09-14 | 2016-07-19 | Infinity Pharmaceuticals, Inc. | Transfer hydrogenation of cyclopamine analogs |
| ITTO20111188A1 (it) | 2011-12-22 | 2013-06-23 | Vhit Spa | Pompa a cilindrata variabile e metodo di regolazione della sua cilindrata |
| AR101476A1 (es) | 2014-08-07 | 2016-12-21 | Acerta Pharma Bv | Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk) |
| CA2988289C (en) | 2015-06-04 | 2023-12-05 | PellePharm, Inc. | Topical formulations for delivery of hedgehog inhibitor compounds and use thereof |
| FI20155779A7 (fi) * | 2015-10-30 | 2017-05-01 | Solani Therapeutics Ltd | Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu |
| US11689849B2 (en) | 2018-05-24 | 2023-06-27 | Nureva, Inc. | Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones |
| KR20260007295A (ko) | 2018-05-24 | 2026-01-13 | 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 | 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치 |
| US11690806B2 (en) | 2018-05-24 | 2023-07-04 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
| CN110559431B (zh) * | 2019-10-11 | 2023-02-28 | 南京农业大学 | 一种巨型艾美耳球虫纳米亚单位疫苗及其制备方法和应用 |
| JP2023509981A (ja) * | 2020-01-10 | 2023-03-10 | エキリーブル バイオファーマシューティカルズ べスローテン フェンノートシャップ | アベルメクチンによる神経障害の治療 |
| BR112023022439A2 (pt) | 2021-04-26 | 2023-12-26 | Celanese Eva Performance Polymers Llc | Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular |
| CN116687882A (zh) * | 2023-07-06 | 2023-09-05 | 杭州高成生物营养技术有限公司 | 一种布洛芬缓释小丸及其制备方法 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3279996A (en) * | 1962-08-28 | 1966-10-18 | Jr David M Long | Polysiloxane carrier for controlled release of drugs and other agents |
| US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4013785A (en) * | 1975-03-21 | 1977-03-22 | Bristol-Myers Company | Apap tablet containing fumed silica and process for manufacturing same |
| US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
| US4331652A (en) * | 1979-09-12 | 1982-05-25 | Eli Lilly And Company | Controlled release parasitic formulations and method |
| US4681583A (en) * | 1982-12-20 | 1987-07-21 | Alza Corporation | System for dispersing drug in biological environment |
| US4578075A (en) * | 1982-12-20 | 1986-03-25 | Alza Corporation | Delivery system housing a plurality of delivery devices |
| DE3681348D1 (de) | 1985-06-11 | 1991-10-17 | Teijin Ltd | Oral-arzneizubereitung mit retardwirkung. |
| SE444801B (sv) | 1985-06-28 | 1986-05-12 | Johan Magnus Ullman | Fender |
| US4786501A (en) | 1985-07-15 | 1988-11-22 | International Minerals & Chemical Corp. | Cylindrical implants for the controlled release of growth hormones |
| US5342622A (en) * | 1986-05-16 | 1994-08-30 | The State Of Victoria | Subdermal biocompatible implants |
| JPH01500899A (ja) * | 1986-05-16 | 1989-03-30 | ザ・ステイト・オブ・ビクトリア | 生物適合性インプラント |
| US5028430A (en) | 1987-05-08 | 1991-07-02 | Syntex (U.S.A.) Inc. | Delivery systems for the controlled administration of LHRH analogs |
| US5035891A (en) * | 1987-10-05 | 1991-07-30 | Syntex (U.S.A.) Inc. | Controlled release subcutaneous implant |
| US5034229A (en) * | 1988-12-13 | 1991-07-23 | Alza Corporation | Dispenser for increasing feed conversion of hog |
| JPH0618958B2 (ja) * | 1989-03-08 | 1994-03-16 | 株式会社クラレ | 多層容器および包装体 |
| DK0463061T3 (da) * | 1989-03-17 | 1993-07-12 | Pitman Moore Inc | Controlled-release tilførselsindretning til afgivelse af makromolekylære proteiner |
| FI916066A0 (fi) * | 1989-06-21 | 1991-12-20 | Univ Brown Res Found | Neurologiskt vaordsystem. |
| US5091185A (en) * | 1990-06-20 | 1992-02-25 | Monsanto Company | Coated veterinary implants |
| AU660290B2 (en) | 1990-08-09 | 1995-06-22 | Endocon, Inc. | Multiple drug delivery system |
| NZ239370A (en) * | 1990-08-22 | 1994-04-27 | Merck & Co Inc | Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone |
| IS3778A7 (is) * | 1990-10-31 | 1992-05-02 | Amgen Inc. | Aðferð til að gefa dýrum vaxtarhormón, þar sem gefnu magni er stýrt |
| US5211951A (en) * | 1991-07-24 | 1993-05-18 | Merck & Co., Inc. | Process for the manufacture of bioerodible poly (orthoester)s and polyacetals |
| JPH06321803A (ja) * | 1993-05-17 | 1994-11-22 | Kirin Brewery Co Ltd | 水溶性ペプチドホルモンの徐放性製剤 |
| JP3720386B2 (ja) * | 1993-12-27 | 2005-11-24 | 住友製薬株式会社 | 薬物放出制御製剤 |
| KR100210509B1 (ko) * | 1996-01-10 | 1999-07-15 | 성재갑 | 지속성 동물 성장 호르몬 제형 및 이의 제조 방법 |
| FR2745180B1 (fr) | 1996-02-23 | 1998-05-07 | Dow Corning Sa | Procede de fabrication de dispositifs a liberation controlee |
| BR9812385A (pt) * | 1997-09-23 | 2000-09-12 | Pfizer | Formulações parasiticidas |
| AUPP279698A0 (en) * | 1998-04-03 | 1998-04-30 | Sunscape Developments Limited | Sustained release formulation |
| AU752225B2 (en) * | 1998-07-17 | 2002-09-12 | Pacira Pharmaceuticals, Inc. | Biodegradable compositions for the controlled release of encapsulated substances |
| AU5532699A (en) * | 1998-09-05 | 2000-03-27 | Seung Jin Lee | Biodegradable particulate polymeric preparation and process for producing thereof |
| MXPA01002609A (es) * | 1998-09-10 | 2002-04-08 | Sumitomo Pharma | Preparacion de farmaco de liberacion sostenida a largo plazo. |
| US6645192B2 (en) * | 1998-09-30 | 2003-11-11 | Ivy Animal Health, Inc. | Pellet implant system for immediate and delayed release of antiparasitic drug |
| WO2000018374A1 (en) | 1998-10-01 | 2000-04-06 | Elan Pharma International, Ltd. | Controlled release nanoparticulate compositions |
| CN1378445B (zh) * | 1999-08-06 | 2013-02-06 | 得克萨斯系统大学评议会 | 药物释放生物可降解纤维植入物 |
| JP4230621B2 (ja) | 1999-08-12 | 2009-02-25 | 住友ゴム工業株式会社 | 空気入りタイヤ |
| JP4757995B2 (ja) * | 1999-11-10 | 2011-08-24 | 大日本住友製薬株式会社 | 薬物放出製剤 |
| TW524696B (en) * | 1999-11-10 | 2003-03-21 | Sumitomo Pharma | Sustained-release drug formulations |
| AU1556000A (en) * | 1999-11-22 | 2001-06-04 | Akzo Nobel N.V. | Composition allowing predefined and controlled release of active ingredient, preparation thereof and use |
| US6998137B2 (en) | 2000-04-07 | 2006-02-14 | Macromed, Inc. | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| JP4504122B2 (ja) | 2004-07-02 | 2010-07-14 | 株式会社マキタ | 生垣バリカン |
-
2001
- 2001-06-29 AU AUPR6024A patent/AUPR602401A0/en not_active Abandoned
-
2002
- 2002-07-01 NZ NZ529858A patent/NZ529858A/en not_active IP Right Cessation
- 2002-07-01 JP JP2003515226A patent/JP4913321B2/ja not_active Expired - Fee Related
- 2002-07-01 CN CNA028131185A patent/CN1536988A/zh active Pending
- 2002-07-01 AU AU2002344686A patent/AU2002344686B2/en not_active Expired
- 2002-07-01 US US10/482,335 patent/US8197839B2/en active Active
- 2002-07-01 CA CA2452075A patent/CA2452075C/en not_active Expired - Fee Related
- 2002-07-01 BR BR0210630-2A patent/BR0210630A/pt not_active IP Right Cessation
- 2002-07-01 WO PCT/AU2002/000866 patent/WO2003009833A1/en not_active Ceased
- 2002-07-01 EP EP02742516A patent/EP1411905A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004535473A5 (https=) | ||
| JP4459444B2 (ja) | 多層構造を有する放出制御製剤 | |
| JP4913321B2 (ja) | 徐放性医薬組成物 | |
| JP2004530721A5 (https=) | ||
| JP4800570B2 (ja) | 徐放性医薬組成物 | |
| JP2005505557A (ja) | 持続放出医薬組成物の調製 | |
| JP2003517014A (ja) | 即放性および徐放性成分を含有する医薬インプラントおよび投与方法 | |
| JPWO1999062501A1 (ja) | 多層構造を有する放出制御製剤 | |
| JP2013049705A (ja) | 持続放出医薬組成物 | |
| AU2002344686A1 (en) | Sustained release delivery system | |
| US20050118271A1 (en) | Polytartrate composition | |
| JP2005522418A5 (https=) | ||
| JP2005517653A5 (https=) | ||
| JP2005517653A (ja) | Ｘ線不透過性徐放性医薬器具 | |
| AU2003201410B2 (en) | Sustained release pharmaceutical composition | |
| AU2003201410A1 (en) | Sustained release pharmaceutical composition | |
| AU2002344687B2 (en) | Treatment of parasitic disease | |
| JP2008500973A (ja) | 持続放出組成物 | |
| AU2002315568A1 (en) | Preparation of sustained release pharmaceutical composition |